Form 4: Chemours Director Pamela Fletcher Acquires Stock Units

Chemours Company Director Pamela Fletcher acquired 7,182 stock units as part of board compensation.

Summary

• Director Pamela Fletcher acquired 7,182 stock units of The Chemours Company (CC).
• The transaction occurred on May 6, 2026.
• The units were acquired at a price of $0, representing equity-based compensation.
• Following this transaction, the director's total beneficial ownership increased to 32,382.9997 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Increased alignment between board members and shareholders through equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The acquired stock units will convert one-for-one to Chemours common stock upon the director's separation from service on the Board.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term board commitment and align director interests with those of public shareholders.

Comparison to Industry Standards

• The acquisition of stock units as board compensation is consistent with standard practices for S&P 500 and chemical industry companies.

Stakeholder Impact

• Shareholders benefit from increased director equity alignment.

Next Steps

• The director will hold these units until separation from the Board.

Key Dates

Keywords

Chemours, CC, Form 4, Insider Trading, Director Compensation, Equity Ownership